StockData
Janux Therapeutics, Inc. logo

Janux Therapeutics, Inc. (JANX) stock

JANXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 12/3037% below fair value
$10.71−0.21 (-1.92%)

Close on Nov 17, 2026Market cap $654.78MP/E –Yield –

Janux Therapeutics enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Janux Therapeutics's enterprise value was -$214.16M on Nov 11, 2026, against $1.06B a year earlier. Over the last 5 years it ranged from -$214.16M to $2.29B, with a median of $239.54M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026-$214.16M–
2025Dec 31, 2025-$159.29M-107.4%
2024Dec 31, 2024$2.14B+1373.7%
2023Dec 29, 2023$145.49M-30.2%
2022Dec 30, 2022$208.46M-50.9%
2021Dec 31, 2021$424.82M–

More Janux Therapeutics figures

See a number that looks wrong?